Schiff profits halved in second quarter

By staff reporter

- Last updated on GMT

Related tags: Profit, Marketing

Sales at Schiff Nutrition, previously known as Weider Nutrition,
fell by a fifth during the second quarter, as the firm discontinued
private label business to focus on more profitable brands.

Revenue for the quarter reached $35.5 million compared to $44.3 million for the same period in fiscal 2005.

Coupled with higher raw material costs, operating profit for the period shrunk to just a quarter of the prior year's quarter, or $1.4 million, while net income fell from $3.46 million to $1.5 million.

Schiff chief executive Bruce Wood said however that the firm was encouraged by strong performance in the firm's branded products at the retail level, despite a slight decline in branded sales during the three-month period.

"Our branded sales declined slightly in the quarter but they are up approximately 8 percent for the first six months,"​ he said in a statement.

The company has recently launched an extension to its Move Free brand that seeks to target the growing number of consumers looking for natural products to beat join pain.

Move Free Advanced is said to be 'two times more effective' in relieving joint pain than triple strength glucosamine and chondroitin alone, and contains hyaluronic acid and a high antioxidant plant extract.

"We will be providing substantial marketing support for this proprietary new product, beginning in our fiscal third quarter,"​ said Wood.

The focus on brands is expected to positively impact fiscal 2007 and beyond, he added.

Related topics: Bone & joint health

Related news

Show more

Related product

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

Related suppliers

Follow us

Products

View more

Webinars